Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Politei

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Molecular Genetics and Metabolism|June 21, 2020
Fabry disease during the COVID-19 pandemic. Why and how treatment should be continuedJuan Politei
Kidney & Blood Pressure Research|April 27, 2025
New Drugs Available for Fabry DiseaseFernando Perretta, Gustavo Cabrera, Juan Politei
Stroke|January 20, 2009
Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry RegistryKatherine Sims, Juan Politei, Maryam Banikazemi, et al.
Molecular Genetics and Metabolism Reports|May 17, 2017
Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in ArgentinaGustavo Cabrera, Juan Politei, Norberto Antongiovani, et al.
Archivos Argentinos De Pediatria|May 28, 2014
[Mucopolysaccharidosis type VI: clinical aspects, diagnosis and treatment with enzyme replacement therapy]Juan Politei, Andrea Schenone, Mariana Blanco, et al.
Lipids|November 12, 2025
Long-Chain Fatty Acid Beta-Oxidation Defects: A Case Series and Literature ReviewJuan Politei, Andrés Berardo, Esteban Calabrese, et al.
Archivos Argentinos De Pediatria|July 15, 2015
[Morquio disease (Mucopolysaccharidosis type IV-A): clinical aspects, diagnosis and new treatment with enzyme replacement therapy]Juan Politei, Andrea B Schenone, Norberto Guelbert, et al.
European Journal of Rheumatology|February 3, 2017
When arthralgia is not arthritisJuan Politei, Graciela Remondino, Ricardo Heguilen, et al.
Medicina|April 8, 2025
Fabry disease in Argentina: clinical, biochemical and molecular correlation in all reported GLA variantsJuan Politei, Romina Ceci, Domingo Procopio, et al.
Plos One|March 16, 2017
Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studiesRegina El Dib, Huda Gomaa, Alberto Ortiz, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Molecular Genetics and Metabolism|June 21, 2020
Fabry disease during the COVID-19 pandemic. Why and how treatment should be continuedJuan Politei
Kidney & Blood Pressure Research|April 27, 2025
New Drugs Available for Fabry DiseaseFernando Perretta, Gustavo Cabrera, Juan Politei
Stroke|January 20, 2009
Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry RegistryKatherine Sims, Juan Politei, Maryam Banikazemi, et al.
Molecular Genetics and Metabolism Reports|May 17, 2017
Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in ArgentinaGustavo Cabrera, Juan Politei, Norberto Antongiovani, et al.
Archivos Argentinos De Pediatria|May 28, 2014
[Mucopolysaccharidosis type VI: clinical aspects, diagnosis and treatment with enzyme replacement therapy]Juan Politei, Andrea Schenone, Mariana Blanco, et al.
Lipids|November 12, 2025
Long-Chain Fatty Acid Beta-Oxidation Defects: A Case Series and Literature ReviewJuan Politei, Andrés Berardo, Esteban Calabrese, et al.
Archivos Argentinos De Pediatria|July 15, 2015
[Morquio disease (Mucopolysaccharidosis type IV-A): clinical aspects, diagnosis and new treatment with enzyme replacement therapy]Juan Politei, Andrea B Schenone, Norberto Guelbert, et al.
European Journal of Rheumatology|February 3, 2017
When arthralgia is not arthritisJuan Politei, Graciela Remondino, Ricardo Heguilen, et al.
Medicina|April 8, 2025
Fabry disease in Argentina: clinical, biochemical and molecular correlation in all reported GLA variantsJuan Politei, Romina Ceci, Domingo Procopio, et al.
Plos One|March 16, 2017
Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studiesRegina El Dib, Huda Gomaa, Alberto Ortiz, et al.
Pageof 4